Invokana and Invokamet (canagliflozin): Drug Safety Communication - New Information on Bone Fracture Risk and Decreased Bone Mineral Density

FDA added a new Warning and Precaution and revised the Adverse Reactions section of the Invokana and Invokamet drug labels.

 
comments powered by Disqus